Invention Grant
US09551713B2 Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
有权
使用一组尿细胞因子来预测膀胱癌对BCG治疗的反应
- Patent Title: Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
- Patent Title (中): 使用一组尿细胞因子来预测膀胱癌对BCG治疗的反应
-
Application No.: US14382374Application Date: 2013-03-04
-
Publication No.: US09551713B2Publication Date: 2017-01-24
- Inventor: Ashish M. Kamat , Joseph Briggman , Colin P. Dinney , Diana Urbauer
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2013/028891 WO 20130304
- International Announcement: WO2013/131093 WO 20130906
- Main IPC: G01N33/574
- IPC: G01N33/574 ; A61K35/74 ; A61N5/10 ; G06F19/00
Abstract:
Methods for predicting cancer recurrence following a BCG immunotherapy are provided. In some aspects, cytokine levels from a patient are measured before and after a BCG therapy and the changes in cytokine levels are used to determine the risk of cancer lapse. Methods for selecting a patient for a further anti-cancer therapy are also provided.
Public/Granted literature
- US20150212090A1 USE OF A PANEL OF URINARY CYTOKINES TO PREDICT RESPONSE TO BCG THERAPY FOR BLADDER CANCER Public/Granted day:2015-07-30
Information query
IPC分类:
